During the past decade, Galiz Research conducted 48 clinical trials. In the 10-year time frame, 48 clinical trials started and 26 clinical trials were completed, i.e. on average, 54.2% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 19 clinical trials were completed. i.e. 82.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Galiz Research" #1 sponsor was "Otsuka Pharmaceutical Development & Commercialization, Inc." with 7 trials, followed by "Sunovion" with 6 trials sponsored, "Celgene" with 5 trials sponsored, "Janssen Research & Development, LLC" with 5 trials sponsored and "Biohaven Pharmaceuticals, Inc." with 5 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Galiz Research" #1 collaborator was "H. Lundbeck A/S" with 3 trials as a collaborator, "Biogen" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "National Institute on Aging (NIA)" with 2 trials as a collaborator and "Cardiokine Biopharma, LLC" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Galiz Research" are "Alzheimer's Disease" (11 trials), "Schizophrenia" (9 trials), "Alzheimer Disease" (7 trials), "Bipolar I Disorder" (5 trials) and "Crohn Disease" (5 trials). Many other conditions were trialed in "Galiz Research" in a lesser frequency.

Most popular intervention types in "Galiz Research" are "Drug" (62 trials), "Other" (6 trials), "Biological" (1 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (38 trials), "Brexpiprazole" (4 trials), "Lurasidone" (4 trials), "Ozanimod" (3 trials) and "AVP-786" (2 trials). Other intervention names were less common.

The vast majority of trials in "Galiz Research" are 65 trials for "All" genders.

Currently, there are NaN active trials in "Galiz Research". undefined are not yet recruiting, 15 are recruiting, 5 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 28 completed trials in Galiz Research, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Galiz Research, 4 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 41 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".